Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry

Court Ruling Could Invalidate Numerous Genome Patents

August 2008 | Industry News

A UK court decision invalidating a patent for a nucleotide and amino acid sequence of the human genome looks set to raise the bar for protecting intellectual property (IP). In the UK's first case relating to the validity of a gene sequence, the court ruled in favour of Eli Lilly after it found that Human Genome Sciences (HGS)' patent on neutrokine-α lacked industrial application, had insufficient evidence and was

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *


If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Western Europe InsightWestern Europe Channels Western Europe Countries